Want to see TFX full AI Analyst Report?
Revenue by Segment
Highlights income from different business units, showcasing which segments drive growth and profitability, and indicating strategic focus areas.
Teleflex is reshaping its revenue mix: management is selling OEM, interventional urology and acute-care assets while adding a large vascular intervention acquisition, shifting scale toward higher-growth Interventional and Vascular Access. That explains the big late‑2025 revenue jump in Interventional and a drop/zeroing in divested units. Near‑term earnings will be hit by stranded costs, tariffs and higher interest, but proceeds and TS/MS offsets (once closed) aim to fund buybacks, debt paydown and margin recovery—timing/execution is the key risk.
TFX Revenue by Segment
| Date | Other | Interventional | Vascular Access | Anesthesia | Surgical | Interventional Urology | OEM |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | $0.00 | $211.87M | $246.34M | $0.00 | $112.12M | $0.00 | $0.00 |
| Mar 31, 2026 | $0.00 | $204.66M | $236.81M | $0.00 | $106.79M | $0.00 | $0.00 |
| Dec 31, 2025 | $0.00 | $217.90M | $240.20M | $0.00 | $110.50M | $0.00 | $0.00 |
| Sep 30, 2025 | $79.08M | $266.41M | $191.02M | $101.45M | $122.88M | $71.77M | $80.41M |
| Jun 30, 2025 | $59.90M | $170.00M | $185.50M | $96.40M | $114.00M | $76.40M | $78.70M |
| Mar 31, 2025 | $53.50M | $137.50M | $182.40M | $86.60M | $105.80M | $71.00M | $63.90M |
| Dec 31, 2024 | $58.20M | $160.40M | $189.30M | $95.30M | $121.90M | $84.90M | $85.40M |
| Sep 30, 2024 | $54.80M | $149.90M | $180.90M | $101.10M | $111.70M | $83.40M | $82.60M |
| Jun 30, 2024 | $41.70M | $141.20M | $181.10M | $102.50M | $111.30M | $83.10M | $88.80M |
| Mar 31, 2024 | $52.40M | $134.70M | $181.40M | $96.40M | $105.50M | $79.70M | $87.70M |
| Dec 31, 2023 | $68.20M | $135.60M | $186.70M | $98.20M | $109.60M | $93.00M | $82.60M |
| Sep 30, 2023 | $76.10M | $134.10M | $169.90M | $97.60M | $112.80M | $73.60M | $82.30M |
| Jun 30, 2023 | $76.00M | $124.80M | $173.80M | $100.80M | $106.00M | $77.80M | $84.10M |
| Mar 31, 2023 | $71.60M | $116.90M | $177.70M | $93.30M | $99.00M | $75.40M | $77.00M |
| Dec 31, 2022 | $73.60M | $125.10M | $186.40M | $99.60M | $110.40M | $89.20M | $73.70M |
| Sep 30, 2022 | $69.90M | $108.70M | $167.10M | $97.60M | $93.10M | $79.00M | $71.30M |
| Jun 30, 2022 | $72.10M | $114.40M | $163.90M | $104.70M | $99.60M | $79.80M | $70.00M |
| Mar 31, 2022 | $69.50M | $96.90M | $166.10M | $86.90M | $89.70M | $74.90M | $57.70M |
| Dec 31, 2021 | $84.70M | $114.90M | $193.00M | $102.80M | $106.40M | $92.90M | $67.20M |
| Sep 30, 2021 | $83.40M | $104.30M | $175.50M | $97.10M | $92.80M | $83.10M | $64.10M |
| Jun 30, 2021 | $86.90M | $112.10M | $167.70M | $95.40M | $98.20M | $92.20M | $61.00M |
| Mar 31, 2021 | $81.70M | $96.20M | $164.00M | $84.90M | $80.40M | $73.40M | $53.50M |
| Dec 31, 2020 | $98.10M | $106.70M | $182.50M | $86.10M | $92.30M | $93.90M | $51.70M |
| Sep 30, 2020 | $86.00M | $93.20M | $160.00M | $75.70M | $82.20M | $81.80M | $49.40M |
| Jun 30, 2020 | $91.40M | $82.60M | $164.90M | $64.90M | $67.30M | $40.10M | $55.80M |
| Mar 31, 2020 | $91.70M | $99.90M | $150.30M | $75.70M | $75.40M | $74.20M | $63.40M |
| Dec 31, 2019 | $89.40M | $112.70M | $154.60M | $85.30M | $95.20M | $89.10M | $54.60M |
| Sep 30, 2019 | $83.90M | $106.90M | $148.70M | $87.10M | $92.60M | $73.60M | $55.40M |
| Jun 30, 2019 | $88.40M | $104.80M | $153.60M | $85.70M | $85.70M | $68.00M | $56.40M |
| Mar 31, 2019 | $85.60M | $103.20M | $143.90M | $80.30M | $86.70M | $59.70M | $54.20M |
